MRVI (STOCKS)
Maravai LifeSciences Holdings, Inc. Class A Common Stock
$3.060000
-0.010000 (-0.33%)
Prev close: $3.070000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bernd Brust
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $784.05M
- Employees
- 560
- P/E (TTM)
- -3.38
- P/B (TTM)
- 2.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
7
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.04 | $-0.07 | +0.0323 | +44.68% |
|
Sep 2025 (Q3)
|
$-0.08 | $-0.08 | +0.0033 | +3.96% |
|
Jun 2025 (Q2)
|
$-0.08 | $-0.07 | -0.0077 | -10.65% |
|
Mar 2025 (Q1)
|
$-0.08 | $-0.07 | -0.0071 | -9.74% |
Financial Statements
| Revenues | $185.74M |
| Benefits Costs and Expenses | $420.72M |
| Cost Of Revenue | $151.75M |
| Costs And Expenses | $249.26M |
| Gross Profit | $33.99M |
| Operating Expenses | $249.26M |
| Selling, General, and Administrative Expenses | $145.12M |
| Research and Development | $17.40M |
| Other Operating Expenses | $86.74M |
| Operating Income/Loss | -$215.27M |
| Income/Loss From Continuing Operations After Tax | -$230.76M |
| Income/Loss From Continuing Operations Before Tax | -$234.97M |
| Income Tax Expense/Benefit | -$4.21M |
| Income Tax Expense/Benefit, Current | -$4.19M |
| Income Tax Expense/Benefit, Deferred | -$20.00K |
| Net Income/Loss | -$230.76M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$99.99M |
| Net Income/Loss Attributable To Parent | -$130.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$130.77M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.90 |
| Diluted Earnings Per Share | -$0.90 |
| Basic Average Shares | 144,360,000 |
| Diluted Average Shares | 144,360,000 |
| Assets | $770.58M |
| Current Assets | $296.25M |
| Inventory | $40.50M |
| Other Current Assets | $255.76M |
| Noncurrent Assets | $474.33M |
| Fixed Assets | $151.48M |
| Intangible Assets | $151.54M |
| Other Non-current Assets | $171.30M |
| Liabilities | $397.87M |
| Current Liabilities | $44.92M |
| Accounts Payable | $2.91M |
| Wages | $11.11M |
| Other Current Liabilities | $30.90M |
| Noncurrent Liabilities | $352.95M |
| Long-term Debt | $291.77M |
| Other Non-current Liabilities | $61.18M |
| Equity | $372.71M |
| Equity Attributable To Noncontrolling Interest | $160.33M |
| Equity Attributable To Parent | $212.38M |
| Liabilities And Equity | $770.58M |
| Net Cash Flow From Operating Activities | -$57.57M |
| Net Cash Flow From Operating Activities, Continuing | -$57.57M |
| Net Cash Flow From Investing Activities | -$31.41M |
| Net Cash Flow From Investing Activities, Continuing | -$31.41M |
| Net Cash Flow From Financing Activities | -$16.50M |
| Net Cash Flow From Financing Activities, Continuing | -$16.50M |
| Exchange Gains/Losses | -$32.00K |
| Net Cash Flow | -$105.51M |
| Net Cash Flow, Continuing | -$105.48M |
| Comprehensive Income/Loss | -$229.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$99.59M |
| Comprehensive Income/Loss Attributable To Parent | -$130.25M |
| Other Comprehensive Income/Loss | $924.00K |